Photo by scottwebb from unsplash
Management of glioblastoma should be aggressive and personalised to increase the quality of life. Many new therapies, such as active immunotherapy, increase the overall survival, yet they result in complications… Click to show full abstract
Management of glioblastoma should be aggressive and personalised to increase the quality of life. Many new therapies, such as active immunotherapy, increase the overall survival, yet they result in complications which render the search for the optimal treatment stra-tegy challenging.
Keywords:
versus radiation;
security dilemma;
glioblastoma;
dilemma active;
active immunotherapy;
immunotherapy versus
Journal Title: Folia medica
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Folia medica
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!